Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
92.6 USD | -0.70% | -0.78% | +8.29% |
09/05 | Haemonetics' Fiscal Q4 Adjusted Earnings, Revenue Rise | MT |
09/05 | Haemonetics Corporation Reports Earnings Results for the Full Year Ended March 30, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.29% | 4.7B | |
-4.91% | 182B | |
+0.46% | 110B | |
-3.62% | 67.92B | |
+3.26% | 50.96B | |
+9.11% | 44.7B | |
+2.30% | 40.66B | |
+6.39% | 27.6B | |
+3.83% | 26.63B | |
+14.04% | 24.84B |
- Stock Market
- Equities
- HAE Stock
- News Haemonetics Corporation
- Raymond James Adjusts Price Target on Haemonetics to $100 From $88, Maintains Outperform Rating